Department of Diagnostic Radiology

Faculty of Medicine

News

News Archive

Subscribe - Nuclear Medicine

Nuclear Medicine

» Full news listing


Donor‑supported nuclear medicine technology attracts top medical talent to the QEII
Donor‑supported nuclear medicine technology attracts top medical talent to the QEII
Angie Kinsman  –  Nuclear Medicine
Friday, March 28, 2025
CAR Practice Guideline on Bone Mineral Densitometry Reporting: 2024 Update
Angie Kinsman  –  Nuclear Medicine
Saturday, January 11, 2025
‘A paradigm shift': A first in Canada, donor‑funded nuclear medicine scanner is helping QEII physicians assess and diagnose diseases with precision that wasn’t previously possible — all while tackling waitlists with greater efficiency
‘A paradigm shift': A first in Canada, donor‑funded nuclear medicine scanner is helping QEII physicians assess and diagnose diseases with precision that wasn’t previously possible — all while tackling waitlists with greater efficiency
Angie Kinsman  –  Nuclear Medicine, Research
Thursday, September 12, 2024
QEII welcomes the first GE StarGuide SPECT‑CT scanner in Canada.
QEII welcomes the first GE StarGuide SPECT‑CT scanner in Canada.
Angie Kinsman  –  Nuclear Medicine
Monday, June 3, 2024
The first 68Ga‑PSMA PET scans in Atlantic Canada mark a new era in prostate cancer assessment
The first 68Ga‑PSMA PET scans in Atlantic Canada mark a new era in prostate cancer assessment
Angie Kinsman  –  Nuclear Medicine
Thursday, May 16, 2024
Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update
Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update
Angie Kinsman  –  Nuclear Medicine
Tuesday, October 10, 2023
No difference in cerebral perfusion between the wild‑type and the 5XFAD mouse model of Alzheimer’s disease
Angie Kinsman  –  Nuclear Medicine
Thursday, December 22, 2022
Intra‑individual comparison of 18F‑sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC‑A1): a multicentre, phase 3 trial
Angie Kinsman  –  Nuclear Medicine
Thursday, December 1, 2022
Lutathera® lutetium (177lu) oxodotreotide for neuroendocrine tumours: a game changer concept in cancer treatment
Angie Kinsman  –  Nuclear Medicine
Thursday, June 30, 2022
Neuroendocrine Tumours: Finding Zebras with Nuclear Medicine
Angie Kinsman  –  Nuclear Medicine
Friday, July 2, 2021
View past items